Now livetag icon
The official Gen AI Landscape report for 2026 is here. Don’t miss out!Get your copybanner icon
Hansoh Pharma

July 2026

Hansoh Pharma Market Share Analysis for July 2026

江苏豪森药业集团有限公司成立于1995年,是一家集药物研发、制造、销售为一体的创新驱动型医药企业,为翰森制药(03692.hk)的重要子公司,致力于通过持续创新提高人类生命质量,重点关注抗肿瘤、抗感染、中枢神经系统类疾病、代谢疾病及自身免疫性疾病等领域。
Domainhansoh.cn
Year Founded1995
Employees5001 - 10000
Annual Revenue> $1B
hansoh.cn
Hansoh Pharma
Hansoh Pharma (including company regionals)
  • hansoh.cn
    hansoh.cn
See more website traffic and engagement information

Hansoh Pharma Revenue up to July 2026 is > 1B

revenue generated by Hansoh Pharma top domains

Hansoh Pharma top domains revenue over 3 years

Revenue for Hansoh Pharma top domains


Total visits to Hansoh Pharma's top domains

Understand Hansoh Pharma market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in Hansoh Pharma's top domains

Analyze Hansoh Pharma engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

Avg. pageviews on Hansoh Pharma's top domains

See how Hansoh Pharma keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.



Top technologies used by Hansoh Pharma

These are the website technologies, by industry, used by Hansoh Pharma top domains

Advertising (1)

PubMatic

PubMatic

Audio Video Media (1)

VideoJS

VideoJS

Conversion & Analytics (1)

CNZZ

CNZZ

Mobile (1)

Meta Viewport

Meta Viewport

More Technologies

1

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from Hansoh Pharma

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsJiangsu Hansoh Pharmaceutical Group invested into Avere Therapeutics on Jul 15th '26.Hansoh Pharmaceutical Group entered into an exclusive license agreement and strategic investment with Avere Therapeutics, an investee company of Hansoh Pharma focused on advancing oral therapies for IL-23 driven inflammatory diseases.
NewsRegeneron partnered with Jiangsu Hansoh Pharmaceutical Group on Jun 2nd '25.US biotech Regeneron Pharmaceuticals (Nasdaq: REGN) today announced a strategic in-licensing agreement with China's Hansoh Pharmaceuticals (03692: HK) for exclusive clinical development and commercial rights outside of the Chinese Mainland, Hong Kong and Macau for a dual GLP-1/GIP receptor agonist currently in Phase III testing.
NewsJiangsu Hansoh Pharmaceutical Group sells assets to Merck.Merck & Co buys in oral GLP-1 RA from china's Hansoh.

See all Hansoh Pharma signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.